Joseph, Anthony
Bullimore, Mark
Drawnel, Faye
Miranda, Marco
Morgan, Zoe
Wang, Yi-Zhong
Funding for this research was provided by:
F. Hoffmann-La Roche AG
Article History
Received: 7 September 2023
Accepted: 6 November 2023
First Online: 28 November 2023
Declarations
:
: Anthony Joseph has no disclosures. Mark Bullimore, in the past 2 years, has served as a consultant for Alcon Research, Inc., Bruno Vision Care LLC, CooperVision, Inc., CorneaGen, Inc., EssilorLuxottica S.A., Euclid Systems, Inc., Eyenovia, Inc., Genentech, Inc., Johnson & Johnson Surgical, Inc., Johnson & Johnson Vision, Inc., Lentechs, Inc., Novartis, AG, Oculus Inc., Sydnexis Inc., Vyluma, Inc., and is the sole owner of Ridgevue Publishing, LLC and Ridgevue Vision LLC. Faye Drawnel was an employee of F. Hoffmann-La Roche AG at the time of the study and is an employee of rainsphere.ai at the time of publication. Marco Miranda holds a patent on a visual function test algorithm and is an employee of Roche Products Ltd. Zoe Morgan is an employee of F. Hoffmann-La Roche AG. Yi-Zhong Wang has served as a consultant for Genentech, Inc. and Roche, and has patents on mobile visual function testing technology.
: This study was conducted in conformance with the Guidelines for Good Pharmacoepidemiology, and all procedures were approved by the Alpha Independent Review Board (IRB00006205). Informed consent was obtained from all study participants.